1,945 reports of this reaction
14.8% of all TRAVOPROST reports
#1 most reported adverse reaction
TREATMENT FAILURE is the #1 most commonly reported adverse reaction for TRAVOPROST, manufactured by Novartis Pharmaceuticals Corporation. There are 1,945 FDA adverse event reports linking TRAVOPROST to TREATMENT FAILURE. This represents approximately 14.8% of all 13,183 adverse event reports for this drug.
Patients taking TRAVOPROST who experience treatment failure should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
TREATMENT FAILURE is a frequently reported adverse event for TRAVOPROST, accounting for a significant proportion of all reports.
In addition to treatment failure, the following adverse reactions have been reported for TRAVOPROST:
The following drugs have also been linked to treatment failure in FDA adverse event reports:
TREATMENT FAILURE has been reported as an adverse event in 1,945 FDA reports for TRAVOPROST. This does not prove causation, but indicates an association observed in post-market surveillance data.
TREATMENT FAILURE accounts for approximately 14.8% of all adverse event reports for TRAVOPROST, making it one of the most commonly reported side effect.
If you experience treatment failure while taking TRAVOPROST, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.